These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25199483)

  • 1. Is topical corticosteroid necessary in traumatic hyphema?
    Türkoğlu EB; Celik T; Celik E; Ozkan N; Bursalı O; Coşkun SB; Alagoz G
    J Fr Ophtalmol; 2014 Oct; 37(8):613-7. PubMed ID: 25199483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid in the treatment of pediatric traumatic hyphema.
    Albiani DA; Hodge WG; Pan YI; Urton TE; Clarke WN
    Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of risk for secondary hemorrhage in traumatic hyphema.
    Rahmani B; Jahadi HR; Rajaeefard A
    Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traumatic hyphema: outcomes of outpatient management.
    Shiuey Y; Lucarelli MJ
    Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of rebleeding in traumatic hyphema.
    Witteman GJ; Brubaker SJ; Johnson M; Marks RG
    Ann Ophthalmol; 1985 Sep; 17(9):525-6, 528-9. PubMed ID: 4062157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
    Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
    Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema.
    Nasrullah A; Kerr NC
    Am J Ophthalmol; 1997 Jun; 123(6):783-90. PubMed ID: 9535622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient management of traumatic hyphemas in children.
    Coats DK; Viestenz A; Paysse EA; Plager DA
    Binocul Vis Strabismus Q; 2000; 15(2):169-74. PubMed ID: 10893460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to the incidence of secondary haemorrhage in 462 patients with traumatic hyphema.
    Ng CS; Strong NP; Sparrow JM; Rosenthal AR
    Eye (Lond); 1992; 6 ( Pt 3)():308-12. PubMed ID: 1446767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Traumatic hyphema caused by eye injuries].
    Luksza L; Homziuk M; Nowakowska-Klimek M; Glasner L; Iwaszkiewicz-Bilikiewicz B
    Klin Oczna; 2005; 107(4-6):250-1. PubMed ID: 16118929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
    Rahmani B; Jahadi HR
    Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to the final visual outcome of 425 patients with traumatic hyphema.
    Ng CS; Sparrow JM; Strong NP; Rosenthal AR
    Eye (Lond); 1992; 6 ( Pt 3)():305-7. PubMed ID: 1446766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
    Derakhshan A; Firoozi J; Esmaeili S; Bakhtiari E; Abbaspour M; Abrishami M; Zia MJ
    J Fr Ophtalmol; 2022 Jan; 45(1):9-12. PubMed ID: 34949502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traumatic hyphema: a critical review of the scientifically catastrophic history of steroid treatment therefore; and A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol.
    Romano PE; Phillips PJ
    Binocul Vis Strabismus Q; 2000; 15(2):187-96. PubMed ID: 10893462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, management and visual outcomes on patients with traumatic hyphema in a reference ophthalmological clinic in Colombia.
    Galvis V; Pedraza-Concha A; Tello A; Plata ML; Escaf CL; Berrospi DR
    Rom J Ophthalmol; 2020; 64(1):28-34. PubMed ID: 32292855
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology and outcomes of hyphema: a single tertiary centre experience of 180 cases.
    Iftikhar M; Mir T; Seidel N; Rice K; Trang M; Bhowmik R; Chun J; Goldberg MF; Woreta FA
    Acta Ophthalmol; 2021 May; 99(3):e394-e401. PubMed ID: 33124159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient management of traumatic microhyphema.
    Recchia FM; Saluja RK; Hammel K; Jeffers JB
    Ophthalmology; 2002 Aug; 109(8):1465-70; discussion 1470-1. PubMed ID: 12153796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of traumatic hyphema.
    Walton W; Von Hagen S; Grigorian R; Zarbin M
    Surv Ophthalmol; 2002; 47(4):297-334. PubMed ID: 12161209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traumatic hyphema in children and adolescents – aetiology and treatment.
    Urban B; Bakunowicz-Łazarczyk A; Michalczuk M
    Klin Oczna; 2016; 118(2):101-4. PubMed ID: 29912487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Williams PB; Gray MK; Crouch ER; Chames M
    Arch Ophthalmol; 1997 Sep; 115(9):1106-12. PubMed ID: 9298049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.